The Boston-based company aims to accelerate the drug discovery process for cancer therapies that are both more effective and less toxic.
AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs
Read more on Forbes - AI
You may also like
news & analysis
Deploying machine learning to improve mental health
February 25, 2022, by Alison Gold | Danny Gross | Abdul Latif Jameel Clinic for Machine Learning in Health
A machine-learning expert and a psychology researcher/clinician may seem an unlikely duo. But MIT’s Rosalind Picard and ...
Read more on MIT News - Artificial intelligence
news & analysis
BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies
October 14, 2021, by PR Newswire:
LONDON, Oct. 14, 2021 /PRNewswire/ — In a significant milestone for its (AI)-driven drug discovery platform, BenevolentAI ...
Read more on PR Newswire:
news & analysis
Pathway Raises $1.3 Million to Scale its AI-Powered Medical Knowledge Platform
October 14, 2021, by Business Wire Technology News
MONTREAL–(BUSINESS WIRE)–A solution to combat medical information overload, a major contributor to clinician burnout.
Read more on Business Wire Technology News
More in DRUG DISCOVERY
news & analysis
Engine Biosciences expands its digital drug discovery pipeline with $43M round
May 27, 2021, by Devin Coldewey
Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. ...
Read more on Artificial Intelligence – TechCrunch
news & analysis
Engine Biosciences expands its digital drug discovery pipeline with $43M round
May 27, 2021, by Devin Coldewey
Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. ...
Read more on Artificial Intelligence – TechCrunch
news & analysis
Interview with Naheed Kurji, Cofounder and CEO of Cyclica
May 12, 2021, by Caroline Lair
We cannot achieve the Sustainable Development Goals unless we end the ‘war on drugs’. Today we meet ...
Read more on The Good AI